Pharmaceutical companies are increasingly adopting decentralized clinical trial methodologies to streamline candidate recruitment and patient retention. The integration of continuous digital monitoring tools has reduced average trial duration by approximately 15%.
Operational Efficiencies and Data Integrity
Remote telemetry devices enable continuous data collection, replacing periodic clinical site visits. This high-frequency data logging provides higher statistical power and reduces sample size requirements for phase II trials.
Regulatory Compliance and Infrastructure Costs
While administrative overhead decreases over time, initial investments in cybersecurity, patient privacy compliance, and validated software platforms present upfront cost barriers for smaller biotechnology firms.